These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10548901)

  • 21. Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement.
    Montplaisir J; Hawa R; Moller H; Morin C; Fortin M; Matte J; Reinish L; Shapiro CM
    Hum Psychopharmacol; 2003 Jan; 18(1):29-38. PubMed ID: 12532313
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of insomnia--the role of zaleplon.
    Richardson GS; Roth T; Kramer JA
    MedGenMed; 2002 Mar; 4(1):9. PubMed ID: 11965211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.
    Greenblatt DJ; Harmatz JS; von Moltke LL; Ehrenberg BL; Harrel L; Corbett K; Counihan M; Graf JA; Darwish M; Mertzanis P; Martin PT; Cevallos WH; Shader RI
    Clin Pharmacol Ther; 1998 Nov; 64(5):553-61. PubMed ID: 9834048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefit-risk assessment of zaleplon in the treatment of insomnia.
    Barbera J; Shapiro C
    Drug Saf; 2005; 28(4):301-18. PubMed ID: 15783240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents.
    Sanger DJ
    CNS Drugs; 2004; 18 Suppl 1():9-15; discussion 41, 43-5. PubMed ID: 15291009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of hypnotic flexibility on patterns of clinical use.
    Lader MH
    Int J Clin Pract Suppl; 2001 Jan; (116):14-9. PubMed ID: 11219327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between psychiatric diseases and insomnia.
    Roth T
    Int J Clin Pract Suppl; 2001 Jan; (116):3-8. PubMed ID: 11219330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia.
    Wagner J; Wagner ML; Hening WA
    Ann Pharmacother; 1998 Jun; 32(6):680-91. PubMed ID: 9640488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
    Hesse LM; von Moltke LL; Greenblatt DJ
    CNS Drugs; 2003; 17(7):513-32. PubMed ID: 12751920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new option for insomnia.
    Scharf M
    Health News; 1999 Oct; 5(12):4. PubMed ID: 10536529
    [No Abstract]   [Full Text] [Related]  

  • 31. Zaleplon loaded bi-layered chronopatch: A novel buccal chronodelivery approach to overcome circadian rhythm related sleep disorder.
    Farag MM; Abd El Malak NS; Yehia SA
    Int J Pharm; 2018 May; 542(1-2):117-124. PubMed ID: 29526622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term treatment with hypnotic drugs for insomnia: going beyond the evidence.
    Baldwin D
    J Psychopharmacol; 2005 Mar; 19(2):134-5. PubMed ID: 15728433
    [No Abstract]   [Full Text] [Related]  

  • 33. "A comparison of the effectiveness of two hypnotic agents for the treatment of insomnia".
    Schwartz T; Nihalani N; Virk S; Jindal S; Costello A; Muldoon R; Azhar N; Hussein J; Tirmazi S
    Int J Psychiatr Nurs Res; 2004 Aug; 10(1):1146-50. PubMed ID: 15468607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insomnia drug. Are there any medications to treat insomnia that won't leave me feeling groggy the next day?
    Johns Hopkins Med Lett Health After 50; 2000 Mar; 12(1):8. PubMed ID: 10740445
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone.
    Drover DR
    Clin Pharmacokinet; 2004; 43(4):227-38. PubMed ID: 15005637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg.
    Allain H; Bentué-Ferrer D; Breton SL; Polard E; Gandon JM
    Hum Psychopharmacol; 2003 Jul; 18(5):369-74. PubMed ID: 12858323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia.
    Walsh JK; Pollak CP; Scharf MB; Schweitzer PK; Vogel GW
    Clin Neuropharmacol; 2000; 23(1):17-21. PubMed ID: 10682226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypnotic efficacy of zaleplon for daytime sleep in rested individuals.
    Whitmore JN; Fischer JR; Storm WF
    Sleep; 2004 Aug; 27(5):895-8. PubMed ID: 15453547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zaleplon increases nocturnal melatonin secretion in humans.
    Morera AL; Abreu-Gonzalez P; Henry M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1013-6. PubMed ID: 19463883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs for Insomnia.
    Med Lett Drugs Ther; 2015 Jul; 57(1472):95-8. PubMed ID: 26147892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.